The FDA on March 5 cleared the Dexcom Stelo Glucose Biosensor System for use, making it the first continuous glucose monitoring device to be available over the counter.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
FDA clears 1st OTC glucose monitor
